Literature DB >> 18293232

Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.

Farzana Kapadia1, David Vlahov, Yingfeng Wu, Mardge H Cohen, Ruth M Greenblatt, Andrea A Howard, Judith A Cook, Lakshmi Goparaju, Elizabeth Golub, Jean Richardson, Tracey E Wilson.   

Abstract

Methadone maintenance is associated with improved adherence to antiretroviral therapies among HIV-positive illicit drug users; however, little information exists on whether adherence is associated with different drug abuse treatment modalities. Using longitudinal data from the Women's Interagency HIV Study, we evaluated the relationship between drug abuse treatment modality and adherence to antiretroviral therapies. In prospective analyses, individuals who reported accessing any drug abuse treatment program were more likely to report adherence to antiretroviral regimens > or = 95% of the time (AOR = 1.39, 95% CI = 1.01-1.92). Involvement in either a medication-based or medication-free program was similarly associated with improved adherence. Drug abuse treatment programs, irrespective of modality, are associated with improved adherence to antiretroviral therapies among drug users. Concerted efforts to enroll individuals with drug use histories in treatment programs are warranted to improve HIV disease outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18293232     DOI: 10.1080/00952990701877052

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  26 in total

1.  Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program.

Authors:  Amy Nunn; Alexandra Cornwall; Jeannia Fu; Lauri Bazerman; Helen Loewenthal; Curt Beckwith
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

2.  Healthcare Empowerment and HIV Viral Control: Mediating Roles of Adherence and Retention in Care.

Authors:  Tracey E Wilson; Emma Sophia Kay; Bulent Turan; Mallory O Johnson; Mirjam-Colette Kempf; Janet M Turan; Mardge H Cohen; Adaora A Adimora; Margaret Pereyra; Elizabeth T Golub; Lakshmi Goparaju; Lynn Murchison; Gina M Wingood; Lisa R Metsch
Journal:  Am J Prev Med       Date:  2018-04-12       Impact factor: 5.043

3.  Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence.

Authors:  Shadi Nahvi; Alain H Litwin; Moonseong Heo; Karina M Berg; Xuan Li; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2011-08-31       Impact factor: 4.492

Review 4.  Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.

Authors:  Cathy M Puskas; Jamie I Forrest; Surita Parashar; Kate A Salters; Angela M Cescon; Angela Kaida; Cari L Miller; David R Bangsberg; Robert S Hogg
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

5.  Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.

Authors:  Barrot H Lambdin; Jennifer Lorvick; Jessie K Mbwambo; John Rwegasha; Saria Hassan; Paula Lum; Alex H Kral
Journal:  Int J Drug Policy       Date:  2017-06-17

6.  Relationship between complementary/alternative treatment use and illicit drug use among a cohort of women with, or at risk for, HIV infection.

Authors:  Daniel J Merenstein; Haihong Hu; Esther Robison; Alexandra M Levine; Ruth Greenblatt; Rebecca Schwartz; Kathleen Weber; Mary Young; Gerald Sharp; Chenglong Liu
Journal:  J Altern Complement Med       Date:  2010-09       Impact factor: 2.579

Review 7.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

8.  The causal effect of opioid substitution treatment on HAART medication refill adherence.

Authors:  Bohdan Nosyk; Jeong E Min; Guillaume Colley; Viviane D Lima; Benita Yip; M-J S Milloy; Evan Wood; Julio S G Montaner
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

9.  Nonstructured treatment interruptions among injection drug users in Baltimore, MD.

Authors:  Ravi Kavasery; Noya Galai; Jacquie Astemborski; Gregory M Lucas; David D Celentano; Gregory D Kirk; Shruti H Mehta
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

10.  Patient and provider comfort discussing substance use.

Authors:  Moira K Ray; Mary Catherine Beach; Christina Nicolaidis; Dongseok Choi; Somnath Saha; P Todd Korthuis
Journal:  Fam Med       Date:  2013-02       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.